We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Published in the Commonwealth of Australia Gazette 1999
Therapeutic Goods Act 1989
I, GRANT TAMBLING, Parliamentary Secretary to the Minister for Health and Aged Care, acting on behalf of the Minister for Health and Aged Care and under subsection 17 (5) of the Therapeutic Goods Act 1989, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods tor listed goods:
- therapeutic goods containing ubidecarenone as an active ingredient and that, for subsection 16 (1) of the Act, are distinct therapeutic goods by reason of having directions for use:
- setting a maximum daily dose for the goods that is no getter than 150 mg; and
- warning that the goods should not be taken if on warfarin therapy, without medical advice;
- therapeutic goods containing honey as an active ingredient, that are not for oral consumption;
- therapeutic goods, for oral consumption, containing honey as an active ingredient and that, for subsection 16 (1) of the Act, are distinct. therapeutic goods by reason of having directions for use warning that the goods are not suitable for use by infants under the age of 12 months.
Dated 23 April 1999
Parliamentary Secretary to the Minister for Health and Aged Care